In 2012, Stryker Corp. voluntarily recalled its Rejuvenate and ABG II hip products, after finding out the implants caused tissue damage and hip pain for patients.
The recall resulted in a one-time $344 million expense during the first quarter of last year, according to Modern Healthcare.
But, that didn't keep the company down.
Now, a year later, the Michigan-based medical device and manufacturing firm reported higher-than expected earning in the first quarter of 2015, and among other things, sales of hip, knee and other orthopedic devices climbed 2.4%, according to the article.
Their revenue in the first quarter increased 3.2%, while medical and surgical equipment revenue increased 4.6%.
